Cargando…
ADMA/SDMA in Elderly Subjects with Asymptomatic Carotid Atherosclerosis: Values and Site-Specific Association
Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase (NOS) inhibitor known as a mediator of endothelial dysfunction and atherosclerosis. Circulating ADMA levels are correlated with cardiovascular risk factors such as hypercholesterolemia, arterial hypertension, diabetes mellitus...
Autores principales: | Riccioni, Graziano, Scotti, Luca, D’Orazio, Nicolantonio, Gallina, Sabina, Speziale, Giuseppe, Speranza, Lorenza, Bucciarelli, Tonino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013635/ https://www.ncbi.nlm.nih.gov/pubmed/24739810 http://dx.doi.org/10.3390/ijms15046391 |
Ejemplares similares
-
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
por: Tsikas, Dimitrios, et al.
Publicado: (2018) -
Marine Carotenoids and Cardiovascular Risk Markers
por: Riccioni, Graziano, et al.
Publicado: (2011) -
Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017) -
Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease
por: Franceschelli, Sara, et al.
Publicado: (2013) -
Leukotrienes in Atherosclerosis: New Target Insights and Future Therapy Perspectives
por: Riccioni, Graziano, et al.
Publicado: (2009)